Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2023-05-18 00:00:00 ET · period of report 2023-05-16 · accession 0001209191-23-030796 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-18 | 2023-05-16 | VKTX | Rowland Charles A Jr | Dir | M - OptEx | $1.08 | +40.0K | 70.0K | +133% | +$43.2K |
| D | 2023-05-18 | 2023-05-16 | VKTX | Rowland Charles A Jr | Dir | S - Sale+OE | $25.00 | -40.0K | 30.0K | -57% | -$1.00M |
| D | 2023-05-18 | 2023-05-16 | VKTX | Rowland Charles A Jr | Dir | M - OptEx | $0.00 | -40.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2023-05-16 | M | A | 40,000 | $1.08 | 70,000 | D | — | — | |
| 2 | Common | Common Stock, par value $0.00001 per share | 2023-05-16 | S | D | 40,000 | $25.00 | 30,000 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-05-16 | M | D | 40,000 | $0.00 | 0 | D | $1.08 · 2018-07-01 to 2027-07-01 | 40,000 Common Stock |